1932

Abstract

“Ion Channels and Neuropharmacology: From the Past to the Future” is the main theme of articles in Volume 60 of the . Reviews in this volume discuss a wide spectrum of therapeutically relevant ion channels and GPCRs with a particular emphasis on structural studies that elucidate drug binding sites and mechanisms of action. The regulation of ion channels by second messengers, including Ca2+ and cyclic AMP, and lipid mediators is also highly relevant to several of the ion channels discussed, including KCNQ channels, HCN channels, L-type Ca2+ channels, and AMPA receptors, as well as the aquaporin channels. Molecular identification of exactly where drugs bind in the structure not only elucidates their mechanism of action but also aids future structure-based drug discovery efforts to focus on relevant pharmacophores. The ion channels discussed here are targets for multiple nervous system diseases, including epilepsy and neuropathic pain. This theme complements several previous themes, including “New Therapeutic Targets,” “New Approaches for Studying Drug and Toxicant Action: Applications to Drug Discovery and Development,” and “New Methods and Novel Therapeutic Approaches in Pharmacology and Toxicology.”

Loading

Article metrics loading...

/content/journals/10.1146/annurev-pharmtox-082719-110050
2020-01-06
2024-06-18
Loading full text...

Full text loading...

/deliver/fulltext/pharmtox/60/1/annurev-pharmtox-082719-110050.html?itemId=/content/journals/10.1146/annurev-pharmtox-082719-110050&mimeType=html&fmt=ahah

Literature Cited

  1. 1. 
    Brown DA. 2020. Neurons, receptors, and channels. Annu. Rev. Pharmacol. Toxicol. 60:9–30
    [Google Scholar]
  2. 2. 
    Brown DA, Adams PR. 1980. Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature 283:673–76
    [Google Scholar]
  3. 3. 
    Duncan AL, Song W, Sansom MSP 2020. Lipid-dependent regulation of ion channels and G protein–coupled receptors: insights from structures and simulations. Annu. Rev. Pharmacol. Toxicol. 60:31–50
    [Google Scholar]
  4. 4. 
    Miyazawa A, Fujiyoshi Y, Unwin N 2003. Structure and gating mechanism of the acetylcholine receptor pore. Nature 423:949–55
    [Google Scholar]
  5. 5. 
    García-Nafría J, Tate CG. 2020. Cryo-electron microscopy: moving beyond X-ray crystal structures for drug receptors and drug development. Annu. Rev. Pharmacol. Toxicol. 60:51–71
    [Google Scholar]
  6. 6. 
    Masiulis S, Desai R, Uchanski T, Serna Martin I, Laverty D et al. 2019. GABAA receptor signalling mechanisms revealed by structural pharmacology. Nature 565:454–59
    [Google Scholar]
  7. 7. 
    Rasmussen SGF, Choi H-J, Rosenbaum DM, Kobilka TS, Thian FS et al. 2007. Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450:383–87
    [Google Scholar]
  8. 8. 
    Shaik MM, Peng H, Lu J, Rits-Volloch S, Xu C et al. 2019. Structural basis of coreceptor recognition by HIV-1 envelope spike. Nature 565:318–23
    [Google Scholar]
  9. 9. 
    Calebiro D, Grimes J. 2020. G protein–coupled receptor pharmacology at the single-molecule level. Annu. Rev. Pharmacol. Toxicol. 60:73–87
    [Google Scholar]
  10. 10. 
    Wootten D, Miller LJ. 2020. Structural basis for allosteric modulation of class B G protein–coupled receptors. Annu. Rev. Pharmacol. Toxicol. 60:89–107
    [Google Scholar]
  11. 11. 
    Santoro B, Shah MM. 2020. Hyperpolarization-activated cyclic nucleotide-gated channels as drug targets for neurological disorders. Annu. Rev. Pharmacol. Toxicol. 60:109–31
    [Google Scholar]
  12. 12. 
    Catterall WA, Lenaeus MJ, Gamal El-Din TM 2020. Structure and pharmacology of voltage-gated sodium and calcium channels. Annu. Rev. Pharmacol. Toxicol. 60:133–54
    [Google Scholar]
  13. 13. 
    Payandeh J, Scheuer T, Zheng N, Catterall WA 2011. The crystal structure of a voltage-gated sodium channel. Nature 475:353–58
    [Google Scholar]
  14. 14. 
    Tang L, Gamal El-Din TM, Swanson TM, Pryde DC, Scheuer T et al. 2016. Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs. Nature 537:117–21
    [Google Scholar]
  15. 15. 
    Zhao Y, Huang G, Wu J, Wu Q, Gao S et al. 2019. Molecular basis for ligand modulation of a mammalian voltage-gated Ca2+ channel. Cell 177:1495–506.e12
    [Google Scholar]
  16. 16. 
    Shen H, Liu D, Wu K, Lei J, Yan N 2019. Structures of human Nav1.7 channel in complex with auxiliary subunits and animal toxins. Science 363:1303–8
    [Google Scholar]
  17. 17. 
    Clairfeuille T, Cloake A, Infield DT, Llongueras JP, Arthur CP et al. 2019. Structural basis of α-scorpion toxin action on Nav channels. Science 363:6433eaav8573
    [Google Scholar]
  18. 18. 
    Wisedchaisri G, Tonggu L, McCord E, Gamal El-Din TM, Wang L et al. 2019. Resting-state structure and gating mechanism of a voltage-gated sodium channel. Cell 178:993–1003.e12
    [Google Scholar]
  19. 19. 
    Man KNM, Navedo MF, Horne MC, Hell JW 2020. β2 adrenergic receptor complexes with the L-type Ca2+ channel CaV1.2 and AMPA-type glutamate receptors: paradigms for pharmacological targeting of protein interactions. Annu. Rev. Pharmacol. Toxicol. 60:155–74
    [Google Scholar]
  20. 20. 
    Cheung PW, Bouley R, Brown D 2020. Targeting the trafficking of kidney water channels for therapeutic benefit. Annu. Rev. Pharmacol. Toxicol. 60:175–94
    [Google Scholar]
  21. 21. 
    Ge J, Li W, Zhao Q, Li N, Chen M et al. 2015. Architecture of the mammalian mechanosensitive Piezo1 channel. Nature 527:64–9
    [Google Scholar]
  22. 22. 
    Xiao B. 2020. Levering mechanically activated Piezo channels for potential pharmacological intervention. Annu. Rev. Pharmacol. Toxicol. 60:195–218
    [Google Scholar]
  23. 23. 
    Brown BM, Shim H, Christophersen P, Wulff H 2020. Pharmacology of small- and intermediate-conductance calcium-activated potassium channels. Annu. Rev. Pharmacol. Toxicol. 60:219–40
    [Google Scholar]
  24. 24. 
    Lee CH, MacKinnon R. 2018. Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. Science 360:508–13
    [Google Scholar]
  25. 25. 
    Matsuda K, Ihara M, Sattelle DB 2020. Neonicotinoid insecticides: molecular targets, resistance, and toxicity. Annu. Rev. Pharmacol. Toxicol. 60:241–55
    [Google Scholar]
  26. 26. 
    Bannister K, Sachau J, Baron R, Dickenson AH 2020. Neuropathic pain: mechanism-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 60:257–74
    [Google Scholar]
/content/journals/10.1146/annurev-pharmtox-082719-110050
Loading
  • Article Type: Introduction
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error